InvestorsHub Logo

kevindenver

06/10/21 8:56 AM

#169797 RE: dadbrotheroftwins #169788

Biogen's drug DOES meet the endpoint of reducing amyloid plaque, what wasn't proven is any measurable clinical improvement to the patient.

misiu143

06/10/21 11:00 AM

#169823 RE: dadbrotheroftwins #169788

No Dadbrotheroftwins ..we know already for a long time that drug don’t need to be very good to be approve by US FDA ....
It must be a BP drug or Dr Fauci favorites , and our Leronlimab in none of the above ..

And dr Fauci .. he started to talk about himself in a 3rd person by now ..
As the saying goes ..

“Power corrupt , and absolute power , corrupt absolutely “

Hopefully even after this hit letter from FDA , at least some of the countries evaluating efficacy and safety of Leronlimab will give us a go ..

And then as our good friend like to say ..

…” Sleep Well Shorts “…

And all imo